NCT07170293 2025-09-12Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid TumorsTianjin Medical University Second HospitalPhase 2 Recruiting15 enrolled
NCT01820299 2018-05-18Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced CancerMedical University of South CarolinaPhase 1 Completed22 enrolled